Management Team
Learn about our management team and the experience that they bring to Hemanext.
Martin Cannon
President, CEO and Board Member
- Previous senior roles at Bain & Company and A. T. Kearny
- BA in Philosophy, Politics and Economics from Oxford University
Eric Newman
Chief Financial Officer
- Previously with TEI Biosciences, Deloitte Touche and BDO Seidman
- BS in Accountancy from Bentley University
- CPA in the Commonwealth of Massachusetts
Daan Kok
Executive Vice President & General Manager, EMEA
- Previously with bluebird bio, Celgene, and P&G
- MSc in International Business from Maastricht University, The Netherlands
Kimberly Dorsch
Vice President of Clinical Affairs
- Previously with LifeNet Health and Sentara Healthcare (Virginia)
- Over 20 years of experience in clinical trial planning and execution
- BS in Cell and Developmental Biology from University of Rochester
Andrew Dunham
PhD – Chief Scientific Officer
- Previously with Baxter Healthcare
- PhD in Environmental Analytical Chemistry from the University of Colorado Boulder
Laurel Omert, MD
Chief Medical Officer
- Previously with CSL Behring and Haemonetics
- Practicing trauma surgeon
- MD from Loyola Stritch School of Medicine and BA in Biology and Psychology from Yale University
Laura Daniels
Vice President of Product Development
- Previously with Haemonetics
- MS and BS in Mechanical Engineering from the Worcester Polytechnic Institute
Robert Haime
Vice President of Commercial Operations
- Previously with Pall Corporation
- MBA from Pace University, BS in Industrial Engineering & Operations Research from Syracuse University
Jill Buckley
Vice President of Human Resources
- Previously with Philips Healthcare
- BA in Psychology from Emmanuel College